Lehmann, K <br/><br/>
Reasons for discontinuing intracavernous injection therapy with prostaglandin E1 (alprostadil).  [electronic resource] 

 -  Urology  Feb 1999 
 - 397-400 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0090-4295 
<br/><br/><label>Standard No.: </label>10.1016/s0090-4295(98)00478-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alprostadil--administration & dosage<br/>Erectile Dysfunction--drug therapy<br/>Humans<br/>Injections<br/>Male<br/>Middle Aged<br/>Penis<br/>Treatment Refusal--statistics & numerical data<br/>Vasodilator Agents--administration & dosage